A detailed history of Morgan Stanley transactions in Rallybio Corp stock. As of the latest transaction made, Morgan Stanley holds 36,484 shares of RLYB stock, worth $36,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,484
Previous 55,085 33.77%
Holding current value
$36,119
Previous $73,000 42.47%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.09 - $1.45 $20,275 - $26,971
-18,601 Reduced 33.77%
36,484 $42,000
Q2 2024

Oct 17, 2024

SELL
$1.34 - $2.98 $28,537 - $63,465
-21,297 Reduced 27.88%
55,085 $73,000
Q2 2024

Aug 14, 2024

SELL
$1.34 - $2.98 $28,537 - $63,465
-21,297 Reduced 27.88%
55,085 $73,000
Q1 2024

Oct 17, 2024

BUY
$1.25 - $2.4 $26,621 - $51,112
21,297 Added 38.66%
76,382 $141,000
Q1 2024

Aug 16, 2024

SELL
$1.25 - $2.4 $28,421 - $54,568
-22,737 Reduced 22.94%
76,382 $141,000
Q1 2024

May 15, 2024

SELL
$1.25 - $2.4 $28,421 - $54,568
-22,737 Reduced 22.94%
76,382 $141,000
Q4 2023

Aug 16, 2024

BUY
$1.91 - $4.39 $84,104 - $193,309
44,034 Added 79.94%
99,119 $236,000
Q4 2023

Feb 13, 2024

BUY
$1.91 - $4.39 $159,183 - $365,871
83,342 Added 528.25%
99,119 $236,000
Q3 2023

Nov 15, 2023

SELL
$3.37 - $6.16 $20,688 - $37,816
-6,139 Reduced 28.01%
15,777 $53,000
Q2 2023

Aug 14, 2023

BUY
$4.31 - $8.89 $54,228 - $111,853
12,582 Added 134.8%
21,916 $124,000
Q1 2023

May 15, 2023

BUY
$4.37 - $8.75 $33,701 - $67,480
7,712 Added 475.46%
9,334 $53,000
Q4 2022

Feb 14, 2023

SELL
$4.67 - $14.86 $22,663 - $72,115
-4,853 Reduced 74.95%
1,622 $10,000
Q3 2022

Nov 14, 2022

SELL
$7.54 - $14.56 $12,599 - $24,329
-1,671 Reduced 20.51%
6,475 $94,000
Q2 2022

Oct 27, 2022

SELL
$6.26 - $13.65 $10,460 - $22,809
-1,671 Reduced 17.02%
8,146 $61,000
Q2 2022

Aug 15, 2022

SELL
$6.26 - $13.65 $10,460 - $22,809
-1,671 Reduced 17.02%
8,146 $61,000
Q1 2022

Oct 27, 2022

BUY
$6.91 - $15.04 $11,546 - $25,131
1,671 Added 20.51%
9,817 $69,000
Q1 2022

May 13, 2022

BUY
$6.91 - $15.04 $13,267 - $28,876
1,920 Added 24.31%
9,817 $69,000
Q4 2021

Feb 14, 2022

BUY
$9.3 - $19.91 $53,428 - $114,382
5,745 Added 266.96%
7,897 $76,000
Q3 2021

Nov 15, 2021

BUY
$10.83 - $23.4 $23,306 - $50,356
2,152 New
2,152 $38,000

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $31.8M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.